Impact of Low-Molecular-Weight (<3 kDa) Camel Milk Casein and Whey Protein Hydrolysates on Hyperglycemia and Associated Hyperlipidemia, Oxidative Stress, and Reproductive Health in Type 2 Diabetic Male Rats
Animal study shows camel milk protein hydrolysates reduce hyperglycemia and oxidative stress in type 2 diabetes, suggesting therapeutic potential for metabolic disorders.
Key Points
Camel milk protein hydrolysates significantly improved hyperglycemia, reducing blood glucose by 66.03% and OGTT to 148.44 mg/dL.
The best results were from the <3 kDa fraction, showing DPP-IV inhibition of 80.67% and increased GLP-1 secretion at 2.68 ng/mL.
Animal study involved diabetic male Wistar rats receiving six weeks of oral hydrolysate administration.
These findings support the use of camel milk protein to enhance insulin secretion and restore reproductive health in diabetes.